Daito Pharmaceutical Co (TSE:4577) Total Equity: 円52,203 Mil (As of Nov. 2025)


TSE:4577 Daito Pharmaceutical Co Ltd TSE:4577
78 GF Score
Price 円1,246.00
GF Value 円1,278.25
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Daito Pharmaceutical Co Total Equity?

Daito Pharmaceutical Co TSE:4577 +0.40% 78 Total Equity is 円52,203 Mil as of Nov. 2025. GuruFocus rates TSE:4577 with a GF Score™ of 78/100 and a GF Value™ of 円1,278.25 (Fairly Valued). The stock has 3 warning signs investors should review.

Daito Pharmaceutical Co's total equity for the quarter that ended in Nov. 2025 was 円52,203 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Daito Pharmaceutical Co Total Equity Historical Data

* Premium members only.

The historical data trend for Daito Pharmaceutical Co's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Daito Pharmaceutical Co Total Equity Chart

Daito Pharmaceutical Co Annual Data
Trend May16 May17 May18 May19 May20 May21 May22 May23 May24 May25
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 41,916.00 47,671.00 50,971.00 52,264.00 52,067.00

Daito Pharmaceutical Co Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 51,615.00 52,067.00 52,213.00 52,203.00 52,334.00
TSE:4577
78GF Score
Daito Pharmaceutical Co Ltd TSE:4577
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Daito Pharmaceutical Co Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Daito Pharmaceutical Co's Total Equity for the fiscal year that ended in May. 2025 is calculated as

Total Equity=Total Assets(Q: May. 2025 )-Total Liabilities(Q: May. 2025 )
=78004-25937
=52,067

Daito Pharmaceutical Co's Total Equity for the quarter that ended in Nov. 2025 is calculated as

Total Equity=Total Assets(Q: Nov. 2025 )-Total Liabilities(Q: Nov. 2025 )
=76842-24639
=52,203

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of 円52,203 Mil mean?
Daito Pharmaceutical Co (TSE:4577) has a Total Equity of 円52,203 Mil as of Nov. 2025. The total amount of equity as record on a company's balance sheet. View historical data for Daito Pharmaceutical Co and its competitors.
Is Daito Pharmaceutical Co's Total Equity too high?
Daito Pharmaceutical Co's current Total Equity is 円52,203 Mil. Overall, Daito Pharmaceutical Co has a GF Score™ of 78/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Daito Pharmaceutical Co's Total Equity compare to ZTS and UTHR?
Daito Pharmaceutical Co's Total Equity of 円52,203 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Drug Manufacturers company?
A good Total Equity depends on the Drug Manufacturers industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Daito Pharmaceutical Co and its competitors. Daito Pharmaceutical Co's current Total Equity is 円52,203 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Daito Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Daito Pharmaceutical Co (TSE:4577) is currently considered Fairly Valued. The stock's GF Value™ is 円1,278.25, compared to a current price of 円1,246.00 — trading 2.5% below its estimated fair value. The current Total Equity is 円52,203 Mil. Daito Pharmaceutical Co's overall GF Score™ is 78/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Daito Pharmaceutical Co (TSE:4577), the current Total Equity is 円52,203 Mil as of Nov. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Daito Pharmaceutical Co (TSE:4577) Overvalued in 2026?

Based on GuruFocus' analysis, Daito Pharmaceutical Co stock appears to be undervalued. The current stock price of 円1,246.00 is trading 2.5% below its estimated GF Value™ of 円1,278.25. GuruFocus considers Daito Pharmaceutical Co to be Fairly Valued.

Key valuation signals for TSE:4577:

  • Total Equity: 円52,203 Mil
  • GF Value™: 円1,278.25 vs. price of 円1,246.00 (2.5% below fair value)
  • GF Score™: 78/100 with 3 warning signs

No single metric tells the full story. See the TSE:4577 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Daito Pharmaceutical Co Business Description

Address 326 Yokamachi, Toyama, JPN, 939-8567
Daito Pharmaceutical Co Ltd is engaged in the research and development of pharmaceutical products. The company also undertakes contract manufacturing.
78GF Score

Get the complete analysis for TSE:4577

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,246.00
Price
円1,278.25
GF Value